home / stock / lmat / lmat articles

LMAT Articles, LeMaitre Vascular Inc. - From 01/11/24

Stock Information
Company Name: LeMaitre Vascular Inc.
Stock Symbol: LMAT
Market: NASDAQ
Website: lemaitre.com
Menu
LMAT LMAT Quote LMAT Short LMAT News LMAT Articles LMAT Message Board
Get LMAT Alerts

News, Short Squeeze, Breakout and More Instantly...
LeMaitre to Present at the 26th Annual Needham Growth Conference | Benzinga

BURLINGTON, Mass., Jan. 11, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that JJ Pellegrino, Chief Financial O...
George LeMaitre At LeMaitre Vascular Capitalizes: Options Exercised, Resulting In $350K | Benzinga

On December 27, it was revealed in an SEC filing that George LeMaitre, Chairman and CEO at LeMaitre Vascular (NASDAQ:LMAT) executed a significant e...

Chairman and CEO At LeMaitre Vascular Sells $2.79M Of Stock | Benzinga

It was reported on December 11, that George LeMaitre, Chairman and CEO at LeMaitre Vascular (NASDAQ:LMAT) executed a significant insider sell, acco...

LeMaitre Vascular Board Member Acquires 7,500 Shares After Exercising Company Stock Options | Benzinga

James John OConnor, Board Member at LeMaitre Vascular (NASDAQ:LMAT), reported a large exercise of company stock options on November 28, according t...
Chairman and CEO at LeMaitre Vascular Exercises Options Worth $678K | Benzinga

George LeMaitre, Chairman and CEO at LeMaitre Vascular (NASDAQ:LMAT), reported a large exercise of company stock options on November 22, according ...

LeMaitre to Participate at Upcoming Investor Conferences in November | Benzinga

BURLINGTON, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that management will be participating...

LeMaitre to Present at the 2023 Cantor Global Healthcare Conference | Benzinga

BURLINGTON, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that David Roberts, President, will ...
Why LeMaitre Vascular Is A Market Leader In Core Segments: Oppenheimer Initiates With Outperform Rating | Benzinga

Oppenheimer has initiated coverage on LeMaitre Vascular Inc (NASDAQ: LMAT) with an Outperform rating and a price target of $70....

Previous 10 Next 10